UPC Analytics
ENDE
Overview · Filed: Aug 29, 2025

UPC_CFI_808/2025

DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS

Provisional measuresProvisional MeasuresParis LDProvisional measuresOral Phase
Plain-English summary

Guardant Health's application for provisional measures against Sophia Genetics entities covering four genomic analysis patents was rejected by the Paris Local Division. The court found EP 3 591 073 (divisional) likely invalid for added matter because the granted claim combined scattered features from the PCT application without clear basis, and found infringement of EP 3 766 986 unproven as reliance on a single press release was insufficient evidence; Guardant had previously withdrawn its request under EP 3 470 533. Guardant was ordered to pay EUR 400,000 in interim costs to Sophia Genetics.

Accepted arguments
What the court agreed with — by party.
  • Added matter in divisional patent EP 3 591 073: granted claim cannot be directly and unambiguously derived from the PCT application as filed

    RespondentLegal basis: Art. 76 EPC; headnote 2-3 of the order

    Note: Court found that selective combinations of scattered fragments from the PCT application without clear indication in the earlier application constitute added matter, making the patent likely invalid.

  • Infringement of EP 3 766 986 not sufficiently proven: reliance on a single press release is insufficient

    RespondentLegal basis: R. 211.2 RoP

    Note: Court held that the burden of proof for infringement lies with the applicant and that a press release alone does not demonstrate how the accused DDM software platform processes data.

Rejected arguments
What the court did not agree with — and why.
  • Three-month delay between learning of potential infringement and filing the PI application constitutes unreasonable delay

    RespondentLegal basis: R. 211.4 RoP

    Reason: Court found three months reasonable given the complexity of the technology and the need to gather evidence across several patents (headnote 1).

  • Indirect infringement under Art. 26 UPCA should be found for EP 3 766 986 even if direct infringement not established

    ClaimantLegal basis: Art. 25-26 UPCA; R. 211.2 RoP

    Reason: Court held that the same insufficient evidence problem applies equally to indirect infringement allegations; reliance on a press release does not satisfy the burden of proof for either direct or indirect infringement.

Claim construction notes

The court did not reach final claim construction for EP 3 766 986 because the infringement evidence was found insufficient. For EP 3 591 073, the court examined whether selected claim features were directly and unambiguously derivable from the PCT parent application, concluding they were not, making the divisional invalid for added matter.